Organisation › Details

Gilead Sciences Inc. (Nasdaq: GILD)

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. *

 

Period Start 1987-06-22 established
  Group Gilead Sciences (Group)
Products Industry biopharmaceutical
  Industry 2 virostatic agent
     
  Street 333 Lakeside Drive
  City 94404 Foster City, CA
    Address record changed: 2015-04-24
     
Basic data Employees n. a.
  Currency USD
  Annual sales 4,230,045,000 (revenues, total, consolidated (2007) 2007-12-31)
  Profit 1,615,298,000 (2007-12-31)
  Cash 2,722,422,000 (2007-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2019-08-04

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 650x99px

More documents for Gilead Sciences (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x113px




» top